Integra LifeSciences Holdings financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$229.83M $277.94M $419.30M $550.46M $654.60M $682.49M $732.07M $780.08M $830.87M $696.83M $796.72M $882.73M $992.08M $1.19B $1.47B $1.52B $1.37B $1.54B $1.56B $1.54B $0.00M
GM % Gross Margin %
61.61% 63.01% 61.03% 62.43% 62.72% 65.17% 64.11% 64.06% 64.13% 62.37% 64.12% 64.98% 66.71% 65.74% 63.53% 64.46% 64.55% 63.34% 63.05% 61.49% 0.00%
OM Operating Margin
10.90% 22.91% 17.14% 14.48% 15.60% 15.65% 15.64% 14.67% 13.71% 11.55% 15.79% 15.49% 16.03% 15.20% 16.02% 17.20% 16.02% 18.07% 17.51% 16.87% 0.00%
EPS Earnings Per Share
$0.65 $0.71 $0.80 $1.05 $1.08 $1.39 $1.40 $1.53 $1.23 $1.48 $1.54 $1.76 $1.94 $2.42 $2.74 $2.45 $3.18 $3.36 $3.10 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0.00% 0.00% 0.00% 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
57.68m 56.1m 55.54m 52.73m 55.29m 56.96m 56.51m 53.64m 54.09m 64.25m 65.58m 73.96m 74.8m 78.48m 85.18m 85.87m 84.27m 84.27m 83.13m 78.18m 78.18m
OCF Operating Cash Flow
$38.98M $56.85M $71.70M $47.03M $72.59M $143.24M $105.57M $104.33M $59.10M $53.27M $83.57M $104.85M $116.41M $114.54M $199.68M $231.43M $203.83M $312.43M $264.47M $139.96M $0.00M
FCF Free Cash Flow
$30.47M $48.80M $60.18M $24.46M $59.19M $118.00M $68.43M $65.90M $-10.32M $5.42M $37.54M $61.07M $69.08M $71.04M $121.94M $161.90M $164.94M $264.41M $222.13M $116.40M $0.00M
FCFS Free Cash Flow Per Share
$0.51 $0.81 $1.03 $0.44 $1.07 $1.99 $1.16 $1.14 $-0.18 $0.19 $0.69 $1.04 $0.93 $0.92 $1.47 $1.13 $1.65 $3.12 $2.62 $0.91 $0.00